SEC Form 4 · accession 0001209191-16-090084
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark G Currie
Officer — Chief Scientific Officer
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Jan 4, 2016 | M | 64,102 | $1.56 | A | 374,102 | D | |
| Class A Common StockF1 | holding | — | — | — | 27,712 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $1.56 | Jan 4, 2016 | M | 64,102 | D | — | Mar 14, 2016 | Class B Common Stock | 64,102 | 10,898 | D |
Explanation of responses
- F1The reporting person acquired 1,614 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2015.
- F2The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2006 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2010.